Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand patents to launch cheaper versions early. This system, created by the Hatch-Waxman Act, saves consumers billions and drives 90% of U.S. prescriptions to generics.
11 Dec 2025
Medicine